EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
TriMas Corporation
TRS

TRS TriMas Corporation

TriMas Corporation · NASDAQ
Market Closed
38.34
▲ ⁦+0.31%⁩ (+0.12)
Market Cap$1.4B
Beta0.60
52w Low52w High
30.4345.43
Last Week
⁦-2.17%⁩
Last Month
⁦-4.72%⁩
Last 3 Months
⁦-6.85%⁩
Last Year
⁦+0.21%⁩
EL7 Factor Analysis
How we score this
Overall77
Strong — clearly above market medianTurnaroundF 5/9Grey zoneBetter than 77% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
74
1.6x▲17.8xTop tier
▸
Growth
69
36.3%▲7.1%Top tier
▸
Quality
48
5.8%▲4.5%Around median
▸
Safety
59
—2.6xAround median
▸
Capital Return
68
0.40%▼2.12%Top tier
▸
Momentum
61
5.6%▲2.9%Around median
▸
Sentiment
63
2▼3Around median
Fair Value
Low confidenceCurrent price$38
Analyst target · 1 analysts
$38
⁦-1%⁩
See it fairly priced
Range ⁦$38–$38⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$38.00
⁦-0.9%⁩
Current Price $38.34·Median $38.00
Low
$38.00
High
$38.00
Street summary

Price Target Analysis for TriMas (TRS)

Bearish tilt

TriMas stock shows a state of stagnation in analyst estimates, with the price target stabilizing at 38 dollars without any change over the past 7 and 30-day periods. The most notable observation is the existence of a negative gap between the current stock price (40.12 dollars) and the consensus price target, indicating that the stock is currently trading at a premium exceeding analyst estimates by approximately 5%.

As of 2026-05-22
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 4.50
Strong Buy
Analyst coverage
2
Buy conviction
100%
High
Target dispersion
0%
Analyst ratings over time2 analysts rating
1
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.50 → 4.50
Recent analyst moves
  • = Reiterate2026-02-26
    KeyBanc
    Overweight· $38.00
  • ⬆ Upgrade2025-08-12
    KeyBanc
    Overweight· $45.00
  • = Reiterate2025-07-30
    BWS Financial
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    1.60x
    4.56x36.49x
    Very cheap
  • Forward P/E
    19.01x
    3.79x30.29x
    Near median
  • EV / EBITDA
    5.57x
    2.75x22.03x
    Very cheap
  • FCF Yield
    -0.8%
    -30.9%16.2%
    Above average
  • Revenue Growth YoY
    36.3%
    -13.8%31.9%
    Exceptional
  • EPS Growth YoY
    2509.8%
    -156.9%135.6%
    Exceptional
  • Gross Margin
    21.0%
    12.0%66.5%
    Below average
  • ROIC
    5.8%
    -23.8%21.5%
    Above average
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    0.4%
    0.1%5.9%
    Low
  • Payout Ratio
    0.7%
    8.9%99.8%
    Low
  • Altman Z-Score
    2.64
    -2.656.14
    Above average
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-30 data

Company Overview

TriMas Corporation is an industrial company that became more focused after divesting TriMas Aerospace and now operates through two main segments. TriMas Packaging generated revenue of $143 million in Q2 fiscal 2026 from packaging solutions serving markets including industrial products, life sciences, beauty and personal care, and food and beverage, while Specialty Products, which benefits from demand for Norris Cylinder products, generated approximately $32 million. Packaging therefore represented about 82% of the company’s quarterly revenue, compared with about 18% for Specialty Products.

In Q2 fiscal 2026, revenue increased 1.6% year over year to $174.6 million, but organic growth was nearly flat, as growth in the industrial and life sciences markets was offset by weakness in beauty and personal care and food and beverage. Gross profit according to EDGAR data was approximately $35.3 million, equivalent to a gross margin of about 20.2%, while net income was $13.4 million and diluted earnings per share were $0.37. On an adjusted basis, operating profit increased 29% to $14.9 million, operating margin expanded 180 basis points to 8.5%, and adjusted earnings per share rose from $0.20 to $0.52.

During the first six months of fiscal 2026, revenue increased 5.8% to $342.9 million, including organic growth of 3.4%, adjusted operating profit increased by more than 30%, and adjusted earnings per share more than doubled to $0.75. The improvement in earnings came from cost reductions, higher interest income on the proceeds from the Aerospace sale, and a lower share count, rather than from a strong acceleration in quarterly revenue alone. The company ended the quarter with more than $1.2 billion in cash and net cash of $846 million, giving it flexibility for organic investment, targeted acquisitions, or returning capital to shareholders.

What's Driving the Stock

  • Management raised the low end of its adjusted earnings per share guidance for fiscal 2026 by $0.10 to a range of $1.60–$1.70, based on progress in cost reductions and stronger-than-expected interest income, while maintaining its sales growth outlook of 3%–6% and an operating margin improvement of more than 300 basis points compared with fiscal 2025.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • Cost-reduction actions totaling $10.5 million during fiscal 2026, with an annualized rate of $16 million, remain on track; they have already helped raise the company’s adjusted operating margin to 8.5% in Q2 fiscal 2026 despite nearly flat organic growth.
  • Norris Cylinder generated revenue growth of 10.2% to approximately $32 million in Q2 fiscal 2026, driven by strong demand and market share gains, prompting management to raise its fiscal 2026 growth guidance for Specialty Products from 3%–6% to 6%–9%.
  • Management expects the completion of the Atkins facility closure and consolidation to support a recovery in food and beverage sales and generate additional savings during the second half of fiscal 2026; the assets were relocated to other sites, and production ramp-up began in late June and July 2026.
  • The company spent $175 million to repurchase more than 5 million shares from the announcement of the Aerospace transaction in November through the end of Q2 fiscal 2026, reducing shares outstanding to approximately 35.9 million, with $76 million remaining under the current repurchase authorization.
  • Liquidity exceeded $1.2 billion, and invested funds generated an average yield of 3.7% during Q2 fiscal 2026; at the same time, the Strategic Investment Committee is evaluating companies in packaging and life sciences that could add products, geographic reach, or new intellectual property, without announcing a transaction or specific timing.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The profitability improvement plan is delivering measurable results: adjusted operating profit increased 29% and margin expanded 180 basis points in Q2 fiscal 2026, despite revenue growth of only 1.6% and nearly flat organic sales.
    • +The financial position combines net cash of $846 million with $400 million of 4.25% notes due in 2029, allowing the company to fund organic growth or targeted acquisitions while retaining flexibility to repurchase shares.
    • +Strong demand at Norris Cylinder provides a clear growth driver; Specialty Products sales increased 10.2%, and management raised its fiscal 2026 growth outlook for the segment to 6%–9%, supported by order activity and the Made in USA label.
    • +The completion of the Atkins facility consolidation and the potential recovery of higher resin costs between Q3 and Q4 fiscal 2026 provide two paths to improved Packaging margins, which maintained an adjusted operating margin of 14.8% despite approximately 100 basis points of price-cost pressure.

    ▼ Selling Case6 pts

    • −Organic growth was nearly flat in Q2 fiscal 2026, and Packaging sales remained at approximately $143 million with little year-over-year growth because of weakness in beauty and personal care and food and beverage; therefore, achieving the segment’s 3%–6% growth guidance depends on a return to organic growth in markets that were flat or declining during the quarter.
    • −Specialty Products faced operational bottlenecks while increasing staffing and production to meet demand, causing its operating profit to decline to $0.7 million from $1.3 million and its margin to fall to 2.2% from 4.4%. The fiscal 2026 margin outlook of 6%–8% reflects temporary labor costs, overtime, overhead, and manufacturing inefficiencies recorded in Q2.
    • −The delayed pass-through of higher resin prices to customers created approximately 100 basis points of pressure on the Packaging margin in Q2 fiscal 2026. Management expects to recover the impact cumulatively between Q3 and Q4, but this remains subject to material price volatility and the ability of quarterly pricing provisions to offset costs.
    • −Free cash flow used $12.9 million in Q2 fiscal 2026, compared with generating $7.7 million in the corresponding period, because of the timing of sales and collections and the concentration of activity in June. The outlook for improvement assumes that these sales convert into collections and that the usual seasonal strength recurs during the second half of fiscal 2026.
    • −The company faces uneven demand across markets, customers, and regions, along with consumer spending pressures, economic and geopolitical uncertainty, supply-chain risks, and tariffs. Although management expects tariffs to have a neutral impact over time, it noted the possibility of policy changes or the future imposition of alternative tariffs.
    • −The sole analyst target is $38, approximately 16.4% below the 52-week range high of $45.43, and the data do not provide a valid current price-to-earnings ratio for comparison. The absence of a diverse range of targets and a usable earnings multiple makes the valuation margin of safety less clear.

    Valuation

    The analyst consensus is “Buy,” but the average, high, and low targets are identical at $38, meaning the data reflect a single target with no dispersion that can be used to assess differences in opinion. This target lies within the 52-week range of $30.43–$45.43; it is approximately 24.9% above the bottom of the range and approximately 16.4% below its peak. A reliable price-to-earnings ratio is not available in the data, and part of the improvement in fiscal 2026 earnings came from interest income and share repurchases, so the positive consensus should be weighed against slow organic growth and the execution risks of the margin improvement plan.

    BuyAnalyst target: $38(-0.9%)

    Figures in the text are as of 2026-09-02; the live price is shown at the top of the page.

    FAQ

    What is TriMas’s core business after the sale of TriMas Aerospace?

    Following the divestiture of Aerospace, TriMas focuses on TriMas Packaging and Specialty Products. Packaging generated revenue of $143 million in Q2 fiscal 2026 from markets including industrial products, life sciences, beauty and personal care, and food and beverage. Specialty Products generated approximately $32 million, driven by demand and market share gains at Norris Cylinder.

    Why did TriMas’s earnings improve more than its sales growth in Q2 fiscal 2026?

    Revenue increased only 1.6% to $174.6 million, and organic growth was nearly flat, but adjusted operating profit increased 29% to $14.9 million. Cost-reduction and efficiency-improvement measures expanded the adjusted operating margin by 180 basis points to 8.5%. Adjusted earnings per share, which increased from $0.20 to $0.52, also benefited from interest income on the proceeds from the Aerospace sale and from the lower share count following repurchases.

    What is TriMas’s guidance for fiscal 2026?

    Management expects company sales growth of 3%–6% and an operating margin improvement of more than 300 basis points compared with fiscal 2025. It raised the low end of its adjusted earnings per share guidance by $0.10 to a range of $1.60–$1.70. The guidance includes growth of 3%–6% in Packaging and growth of 6%–9% with a margin of 6%–8% in Specialty Products.

    What is the impact of the Atkins facility closure on TriMas Packaging’s results?

    The process of transferring capacity from the Atkins facility temporarily disrupted part of the production capacity, pressuring food and beverage sales in Q2 fiscal 2026. Management said on July 30, 2026, that the asset transfer had been completed and the facility had been closed, after production ramp-up began at the receiving sites in late June and July 2026. The company expects the consolidation to support additional savings and margin improvement during the second half of fiscal 2026, while fulfilling demand that could not be converted into sales during the transfer.

    How could TriMas use the proceeds from the Aerospace sale?

    TriMas ended Q2 fiscal 2026 with more than $1.2 billion in cash and net cash of $846 million. Management and the Strategic Investment Committee are evaluating organic growth opportunities and targeted acquisitions in packaging and life sciences, but they have not announced a transaction or specific timing. By the end of the quarter, the company had spent $175 million to repurchase more than 5 million shares, with $76 million remaining under the current authorization, while invested funds generated an average yield of 3.7% during the quarter.

    What are the main profitability risks at Norris Cylinder?

    Sales at Specialty Products, which benefits from Norris Cylinder, increased 10.2% to approximately $32 million in Q2 fiscal 2026. However, difficulties in increasing staffing and production capacity raised temporary labor costs, overtime, and overhead, causing the operating margin to fall to 2.2% from 4.4%. The company has begun adjusting staffing levels, spending, and production scheduling and is evaluating further automation, but the fiscal 2026 margin guidance of 6%–8% remains dependent on improved efficiency and execution.